Business Description
FullHope Biomedical Co Ltd
ISIN : TW0007773004
Total Employee Number:
35Description
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 43.79 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 32.36 | |||||
Beneish M-Score | 30.16 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.3 | |||||
3-Year EBITDA Growth Rate | 21.3 | |||||
3-Year EPS without NRI Growth Rate | 18 | |||||
3-Year FCF Growth Rate | 28.5 | |||||
3-Year Book Growth Rate | 97.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.39 | |||||
9-Day RSI | 41.67 | |||||
14-Day RSI | 43.31 | |||||
3-1 Month Momentum % | 25.65 | |||||
6-1 Month Momentum % | -4.15 | |||||
12-1 Month Momentum % | -18.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 19.93 | |||||
Quick Ratio | 19.61 | |||||
Cash Ratio | 19.23 | |||||
Days Inventory | 231.04 | |||||
Days Sales Outstanding | 17.23 | |||||
Days Payable | 53.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.22 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.8 | |||||
Operating Margin % | -109.67 | |||||
Net Margin % | -89.33 | |||||
EBITDA Margin % | -67.08 | |||||
FCF Margin % | -56.12 | |||||
OCF Margin % | -54.36 | |||||
ROE % | -6.86 | |||||
ROA % | -6.6 | |||||
ROIC % | -44.84 | |||||
3-Year ROIIC % | -1.75 | |||||
ROC (Joel Greenblatt) % | -120.65 | |||||
ROCE % | -6.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 25.32 | |||||
PB Ratio | 2 | |||||
Price-to-Tangible-Book | 2.01 | |||||
EV-to-EBIT | -20.2 | |||||
EV-to-EBITDA | -26.67 | |||||
EV-to-Revenue | 17.89 | |||||
EV-to-FCF | -31.87 | |||||
| Price-to-Net-Current-Asset-Value | 3.42 | |||||
| Price-to-Net-Cash | 3.55 | |||||
Earnings Yield (Greenblatt) % | -4.95 | |||||
FCF Yield % | -2.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
FullHope Biomedical Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 43.6 | ||
| EPS (TTM) (NT$) | -0.98 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 35.34 | ||
| 14-Day RSI | 43.31 | ||
| 14-Day ATR (NT$) | 1.076781 | ||
| 20-Day SMA (NT$) | 28.4425 | ||
| 12-1 Month Momentum % | -18.93 | ||
| 52-Week Range (NT$) | 19.9 - 49.8 | ||
| Shares Outstanding (Mil) | 39.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
FullHope Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
FullHope Biomedical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
FullHope Biomedical Co Ltd Frequently Asked Questions
What is FullHope Biomedical Co Ltd(ROCO:7773)'s stock price today?
The current price of ROCO:7773 is NT$27.65. The 52 week high of ROCO:7773 is NT$49.80 and 52 week low is NT$19.90.
When is next earnings date of FullHope Biomedical Co Ltd(ROCO:7773)?
The next earnings date of FullHope Biomedical Co Ltd(ROCO:7773) is .
Does FullHope Biomedical Co Ltd(ROCO:7773) pay dividends? If so, how much?
FullHope Biomedical Co Ltd(ROCO:7773) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on FullHope Biomedical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers